- Investigator
- Francesco Franchi
- Status
- Accepting Candidates
- Ages
- 18 Years - N/A
- Sexes
- All
Treats Adults
Francesco Franchi, MD
Cardiologist
- Additional languages:
- Italian
(904) 383-1011
Request appointment online
Research at a glance
Top areas of exploration
- Platelet Aggregation Inhibitors , 83 publications
- Percutaneous Coronary Intervention , 49 publications
- Purinergic P2Y Receptor Antagonists , 43 publications
- Clopidogrel , 36 publications
Research activity
Active clinical trials
- Investigator
- Francesco Franchi
- Status
- Accepting Candidates
- Ages
- 18 Years - N/A
- Sexes
- All
- Investigator
- Francesco Franchi
- Status
- Accepting Candidates
- Ages
- 18 Years - N/A
- Sexes
- All
My publications
Filter publications
143 publications
2025
Platelet reactivity when switching from cangrelor to oral P2Y12 receptor inhibitors: insights from a real-world registry.
EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology
鈥�2025
Cangrelor in Patients With Cardiogenic聽Shock or Cardiac Arrest
JACC: Cardiovascular Interventions
2025
Switching from cangrelor to oral P2Y12 inhibitors: a focused review on drug-drug interactions.
Expert opinion on drug metabolism & toxicology
鈥�2024
International Consensus Statement on Platelet Function and Genetic Testing in Percutaneous Coronary Intervention
JACC: Cardiovascular Interventions
2024
Comparative effects of different antiplatelet strategies in carriers of CYP2C19 loss-of-function alleles: a network meta-analysis.
European heart journal. Cardiovascular pharmacotherapy
鈥�